Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate
Product Images NDC 0115-1333

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 0115-1333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Global Pharmaceuticals, Division Of Impax Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amphetamine 1)

This appears to be a table of mean plasma concentrations of dextro and levoamphetamine in nmol/L over a period of 24 hours, with data points at 0, 4, 8, 12, 16, 20, and 24 hours. It also includes medication dosages for Maser and Adderall at different frequencies.*

FDA Label Image

Principal Display Panel (5 mg Bottle Label)

This is a label of a medication called Dextroamphetamine Saccharate. It contains Amphetamine Aspartate Monohydrate and is an extended-release capsule. There are 100 capsules, and the unique identifier of the product is 0115-1328-013.*

FDA Label Image

Principal Display Panel (10 mg Bottle Label)

This seems to be a product label for Dextroamphetamine and Amphetamine Extended-Release Capsules. It includes details such as the NDC number, manufacturer details, and quantity. There are also some illegible characters and numbers that can’t be identified.*

FDA Label Image

Principal Display Panel (15 mg Bottle Label)

FDA Label Image

Principal Display Panel (20 mg Bottle Label)

This is a description of a medication product "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate" which comes in capsule form. The product contains mixed salts of a single-entity amphetamine and is an extended-release capsule. The capsule comes in 20 mg and contains 100 capsules. The product is manufactured by Global Pharmaceuticals, which is a division of IMPAX Laboratories Inc. It must be supplied by Shira LLC located in Florence, KY 41042.*

FDA Label Image

Principal Display Panel (25 mg Bottle Label)

This text appears to be a mix of random numbers, codes, and medicine product information. It includes the name of a mixture of dextroamphetamine sulfate and amphetamine sulfate, as well as the form of the drug (extended-release capsules) and its packaging details (100 capsules). There is no coherent description that can be inferred from this text.*

FDA Label Image

Principal Display Panel (30 mg Bottle Label)

This appears to be a combination of text including some gibberish characters and some useful information. It mentions names of various chemical compounds and their types and forms, along with their dosage. It also displays some important information regarding prescription, including cautionary notes. The text seems to be related to a pharmaceutical product, possibly a medicine.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.